Approved Study Database
Ref. No. | Scientific Title | Principal investigator |
---|---|---|
2018.232 | Search for Maturity-Onset Diabetes of the Young in Chinese with Young-Onset Diabetes | Dr. LUK Andrea On Yan |
2020.032 | Health and Economic Impacts of Pre-Diabetes, Gestational Diabetes, Type 1 and Type 2 Diabetes in Hong Kong |
Dr. LUK Andrea On Yan 陸安欣 |
2020.132 | A Trial Investigating the Pharmacokinetic Properties of Fast-acting Insulin Aspart in Chinese Subjects with Type 1 Diabetes or Type 2 Diabetes |
Dr. LUK Andrea On Yan 陸安欣 |
2020.438 | Delineating the metabolic architecture and response to anti-hyperglycaemic drug treatment in lean type 2 diabetes in Chinese | Dr. LUK Andrea On Yan |
2020.689 | ReFineDR: Observational study of Routine ophthalmological examinations of patients included in the 2 Bayer sponsored phase 3 clinical trials FIDELIO and FIGARO to investigate the effect of Finerenone on delaying the progression of Diabetic Retinopathy |
Dr. LUK Andrea On Yan 陸安欣醫生 |
2011.418 | A Multicenter, Controlled, Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of Evolocumab (AMG 145) | Dr. LUK Andrea On Yan |
2011.084 | A randomized controlled study to evaluate the effect of n-3 polyunsaturated fatty acids on the progression of diabetic kidney disease | Dr Luk Andrea On Yan |
2013.588 | RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS CARDIOVASCULAR OUTCOMES FOLLOWING TREATMENT WITH ERTUGLIFLOZIN (MK-8835/PF-04971729) IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS AND ESTABLISHED VASCULAR DISEASE, THE VERTIS CV STUDY | Dr. LUK Andrea On Yan |
2012.489 | A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess Cardiovascular Outcomes Following Treatment with MK-3102 in Subjects with Type 2 Diabetes Mellitus | Dr. LUK Andrea On Yan |
2013.070 | A Multicenter, Controlled, Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of AMG 145 | Dr. LUK Andrea On Yan |
2013.071 | A Multicenter, Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 145 on LDL-C in Subjects With Severe Familial Hypercholesterolemia | Dr. LUK Andrea On Yan |
2011.182 | A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment with Exenatide Once Weekly in Patients with Type 2 Diabetes Mellitus | Dr. LUK Andrea On Yan |
2012.482 | Descriptive study of clinical profile of Hong Kong diabetic population | Dr Luk Andrea On Yan |
2014.441 | A MULTICENTRE RANDOMIZED PROGRAM BY USING A DIABETIC KIDNEY DISEASE (DKD) REGISTRY TO TREAT TO MULTIPLE TARGETS (TMT) (DKD-TMT) | Dr. LUK Andrea |
2015.487 | Retinopathy of Prematurity: Applicability and Compliance of Screening Guidelines in Hong Kong | Dr. LUK Abbie Sheung Wan |
2014.016 | Surgical Outcome of Medial Rectus Resection for Recurrent Exotropia | Dr. LUK Abbie |
2009.369 | Determinants and barriers for help seeking in persons with self-harm and aggressive ideations | Dr Lui Wing Cheong Victor |
2008.365 | Validation Study of Assessment of Capacity for Everday Decision-Making for Chinese Elderly | Dr Lui Wing Cheong |
2009.442 | Retrospective review of medical records to investigate the difference in the survival rate of out-of-hospital cardiac arrest patients before and after the implementation of 2005 Resuscitation Guildelines | Ms Lui Wai Yee Carrie |
2008.195 | High-Content Screening (HCS) Platform for Molecular Drug Testing, Therapeutic Target Identification and Mechanistic Signaling Studies in Asian Prevalent Cancers | Ph.D., Assistant Professor LUI Wai Yan Vivian |
2008.196 | Biological Implication of Elefated Serum Hepatocyte Growth Factor (HGF) in the Progressionof Nasopharyngeal Carcinoma (NPC) | Ph.D., Assistant Professor LUI Wai Yan Vivian |
2008.022 | Oncogenic Dependency on Receptor Tyrosine Kinase (RTK): Implication for Molecular Targeting in Nasopharyngeal Carcinoma (NPC) | Ph.D., Assistant Professor LUI Wai Yan Vivian |
2011.612 | Comparison of satisfaction with communication during general outpatient consultation of doctors and patients | Ms Lui Wai Yan |
2010.081 | Oncogenic Regulation of TIGAR by STAT3: A Mechanistic Study | Ph.D. LUI Vivian Wai Yan |
2017.293 | ALK/PIK3CA Genetic Coupling: Implications for Progression and Personalized Therapy in Head and Neck Cancer |
Dr. LUI Vivian Wai Yan 呂偉欣 |
2017.145 | RAC1 Genomic Alterations Drive Head and Neck Cancer Progression |
Dr. LUI Vivian Wai Yan 呂偉欣 |
2011.282 | EFFECTIVENESS OF TOE SPREADER & DYNAMIC HALLUX VALGUS STRAP ON FOOT FUNCTION FOR JUVENILE HALLUX VALGUS - PROSPECTIVE, CROSSOVER RANDOMIZED CONTROL TRIAL | Dr. Lui Tun Hing |
2025.139 | Epidemiology of fusariosis in NTEC | Dr. LUI Tin Long |
2009.282 | Socio-demographic Risk Factors for adolescent Sports Injury in Hong Kong: A Pilot Study | Ms Lui Tai Wah |
2022.323 | Effectiveness of the Current Use of Hospital Authority (HA) Mobile Application HA Go in Exercise Program for Knee Osteoarthritis (OA) in Local Elderly Patients |
Ms. LUI Sweetie R. 雷蕢珊 |
2023.490 | International Liver cAncer Database (ILIAD) Consortium Study | Dr. LUI Rashid N.S. |
2023.465 | Normal saline versus lactated Ringer’s solution for acute pancreatitis resuscitation, an open-label multicenter randomized controlled trial: the WATERLAND trial | Dr. LUI Rashid N.S. |
2022.371 | Multicentre assessment of liver frailty using the Liver frailty index in patients with unresectable hepatocellular carcinoma (HCC) undergoing transarterial chemoembolisation (TACE) or systemic therapy | Dr. LUI Rashid N.S. |
2019.304 | Single Arm, Open-label Trial on the Efficacy of Pantoprazole, Amoxicillin and Clarithromycin Triple Therapy for 14 Days as First-line Therapy for Helicobacter pylori in Hong Kong and Outcomes of Targeted Screening for Household Members |
Dr. LUI Rashid N. 雷諾信 |
2019.507 | Helicobacter pylori, Atrophic Gastritis and Intestinal Metaplasia Registry | Dr. LUI Rashid |
2020.588 | Guangzhou-Oxford-Taipei-HongKong International Collaborative Sessile Serrated Lesion Study | Dr. LUI Rashid |
2021.145 | Multicenter prospective study of colorectal serrated lesions in the Asia-Pacific region | Dr Lui Rashid |
2021.217 | coMpliAnce with evideNce-based cliniCal guidelines in the managemenT of acute biliaRy pancreAtitis (MANCTRA-1). | Dr Lui Rashid |
2022.033 | Clinico-genomic predictors of outcomes among patients with HIV and cancer | Dr. LUI Rashid |
2024.012 | Comparison of Functioning Among Dementia Patients with and without Getting Lost | Miss LUI Pui Yin |
2022.426 | Effect of a Novel Herbal Patch for the Treatment of Plantar Fasciitis – A Single-blind Randomized Controlled Trial |
Prof. LUI Pauline Po Yee 呂寶儀 |
2024.105 | Development of a Biobank for Studying the Pathogenesis and Treatment of Musculoskeletal Disorders |
Prof. LUI Pauline Po Yee 呂寶儀 |
2022.242 | Pulsed electromagnetic fields (PEMF) in knee osteoarthritis: a double-blind, placebo-controlled, randomised clinical trial |
Prof. LUI Pauline Po Yee 呂寶儀 |
2022.346 | The Effect of Oral Administration of Alendronate on Knee Functions following Anterior Cruciate Ligament Reconstruction – A Double-Blind, Placebo-Controlled, Randomized Trial |
Prof. LUI Pauline Po Yee 呂寶儀 |
2022.516 | Efficacy of Red-light Therapy in Potentiating the Effect of a Novel Herbal Paste for the Treatment of Rotator Cuff Tendinopathy |
Prof. LUI Pauline Po Yee 呂寶儀 |
2024.130 | Effect of Pulsed Electromagnetic Fields on Promoting Hamstring Muscle Strength after Anterior Cruciate Ligament Reconstruction with Hamstring Autograft: A Double-Blind, Placebo-Controlled, Randomised Clinical Trial | Prof. LUI Pauline Po Yee |
2025.214 | Investigating the Prevalence of Tendinopathy in Patients with Metabolic Syndrome: The Impact of Metabolic Drugs | Prof. LUI Pauline Po Yee |
2021.033 | Randomized Controlled Trial of Aspirin for the Prevention of Recurrence in Liver Cancer |
Dr Lui Nok Shun Rashid 雷諾信 |
2023.381 | Consultancy Study on Review of Comprehensive Child Development Service |
Ms. LUI Man Yi 雷敏儀 |
2011.251 | Shape Analysis Using computational Quasi-conformal Geometry | Prof. LUI LOK MING |
Page 101 of 262.